Delayed onset muscle soreness: what is it and how do we treat it?

Gespeichert in:
Bibliographische Detailangaben
Deutscher übersetzter Titel:Muskelkater: was ist das und wie behandeln wir ihn?
Autor:Gulick, D.T.; Kimura, I.F.
Erschienen in:Journal of sport rehabilitation
Veröffentlicht:5 (1996), 3, S. 234-243, Lit.
Format: Literatur (SPOLIT)
Publikationstyp: Zeitschriftenartikel
Medienart: Gedruckte Ressource
Sprache:Englisch
ISSN:1056-6716, 1543-3072
Schlagworte:
Online Zugang:
Erfassungsnummer:PU199703203238
Quelle:BISp

Abstract des Autors

Muscle soreness, a familiar phenomenon to most athletes, has been differentiated into "acute" and "delayed onset". The etiology of acute muscle soreness has been attributed to ischemia and the accumulation of metabolic by-products. However, the etiology of delayed onset muscle soreness (DOMS) ist not so clear. Six theories have been proposed: lactic acid, muscle spasm, torn tissue, connective tissue, enzyme efflux, and tissue fluid theories. The treatment of DOMS has also been investigated. Studies in which ant-inflammatory medications have been administered have yielded varying results based on the dosage and the time of administration. Submaximal concentric exercise may alleviate soreness but does not restore muscle function. Neither cryotherapy nor stretching abates the symptoms of DOMS. Transcutaneous electrical stimulation has been shown to decrease soreness and increase range of motion, but the effect on the recovery of muscle function is unknown. Therefore, the treatment of DOMS remains an enigma. Verf.-Referat